Related Experiment Video
Updated: Jan 29, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma
Xin Wang1, Qing Zhang2, Changji Li3
1Department of Dermatology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Abstract:
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. Several previous studies have shown that fibulin-3 participates in the occurrence and development of various tumors; however, its role in cSCC remains unknown. In the present study, we observed that the expression of fibulin-3 was downregulated in cSCC tissues compared with normal skin tissues, which was due to fibulin-3 promoter methylation. In vitro, knockdown of fibulin-3 in cSCC cell lines A431 and SCL-1 cells promoted cell proliferation, protected cells against apoptosis and enhanced migration and invasion abilities. Conversely, overexpression of fibulin-3 inhibited cell proliferation by promoting growth arrest during the G1/S phase transition, induced apoptosis, and reduced migration and invasion abilities. These anticarcinogenic effects of fibulin-3 were associated with inhibition of the AKT signaling pathway. Through a mouse xenograft model, we found that fibulin-3 overexpression inhibited the cSCC tumor growth in vivo. Our results suggest that fibulin-3 has anti-tumorigenic activities in cSCC. Downregulation of fibulin-3 is involved in cSCC development and it may serve as a novel therapeutic target of this disease.
Insights
Fibulin-3, a protein, is downregulated in cutaneous squamous cell carcinoma (cSCC). Restoring fibulin-3 inhibits cSCC growth, proliferation, and metastasis, suggesting it
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent skin cancer globally.
- Fibulin-3's role in cSCC tumorigenesis has not been previously elucidated.
- Altered gene expression and epigenetic modifications, like promoter methylation, are implicated in cancer development.
Purpose of the Study:
- To investigate the expression status and functional role of fibulin-3 in cutaneous squamous cell carcinoma.
- To determine the underlying mechanism of fibulin-3 downregulation in cSCC.
- To evaluate fibulin-3's potential as a therapeutic target for cSCC.
Main Methods:
- Quantitative analysis of fibulin-3 expression in cSCC tissues versus normal skin.
- Assessment of fibulin-3 promoter methylation status.
- In vitro studies using cSCC cell lines (A431, SCL-1) with fibulin-3 knockdown and overexpression.
- Cellular assays measuring proliferation, apoptosis, migration, and invasion.
- Western blot analysis to assess the AKT signaling pathway.
- In vivo mouse xenograft model to evaluate tumor growth inhibition.
Main Results:
- Fibulin-3 expression was significantly downregulated in cSCC tissues, correlated with promoter methylation.
- Fibulin-3 knockdown promoted cSCC cell proliferation, survival, migration, and invasion.
- Fibulin-3 overexpression inhibited proliferation, induced G1/S phase arrest, promoted apoptosis, and reduced migration/invasion.
- Fibulin-3's anti-tumorigenic effects were linked to the inhibition of the AKT signaling pathway.
- Overexpression of fibulin-3 suppressed cSCC tumor growth in vivo.
Conclusions:
- Fibulin-3 exhibits significant anti-tumorigenic properties in cutaneous squamous cell carcinoma.
- Downregulation of fibulin-3, driven by promoter methylation, contributes to cSCC progression.
- Fibulin-3 represents a promising novel therapeutic target for cSCC treatment.
Related Concept Videos
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
tRNA Activation
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Waterproofing and Anti-Bacterial Admixtures in Concrete
Waterproofing admixtures render concrete hydrophobic,...

